期刊文献+

老年原发性高血压患者血栓前状态及药物干预 被引量:12

Prothrombotic state and drug interference in elderly hypertensive patients
暂未订购
导出
摘要 目的 研究老年原发性高血压患者血栓前状态 (PTS)分子标志物的变化及血管紧张素转换酶抑制剂 (ACEI)与血管紧张素Ⅱ受体 1(AT1)拮抗剂对原发性高血压患者血栓前状态的影响。  方法  测定 40例老年原发性高血压患者及 2 0例与原发性高血压患者年龄、性别相匹配的正常对照组血浆纤维蛋白原 (Fbg)、假性血友病因子 (vWF)、P 选择素、凝血酶原激活物抑制剂 1(PAI 1)。将 40例老年高血压病患者随机分成 2组 ,依拉普利组 2 0例 ,10~ 2 0mg每日口服 ;氯沙坦组 2 0例 ,5 0~ 10 0mg每日口服 ,治疗 8周后测Fbg、vWF、P 选择素、PAI 1。  结果 老年高血压组治疗前Fbg(P <0 0 1)、vWF(P <0 0 5 )、P 选择素 (P <0 0 5 )、PAI 1(P <0 0 5 )显著高于对照组 ,药物治疗后 2组Fbg、vWF、P 选择素、PAI 1均较用药前降低 ,差异有显著性 (P均 <0 0 5 ) ,而 2组间血栓前状态指标降低无显著性差异。  结论  老年高血压患者存在血栓前状态 。 Objective To investigate the changes of the haemostatic markers in elderly hypertensive patients,and effects of angiotensin converting enzyme inhibitor(ACEI) and angiotensin Ⅱ type 1 receptor(AT1) antagonist on prothrombotic state. Methods Fbg,vWF,P-selectin,PAI-1 were detected in 40 elderly hypertensive patients and 20 sex and age-matched healthy controls.40 untreated elderly hypertensive patients were divided into two groups randomly.20 patients were treated with enalapril(10~20 mg·d -1 ) and 20 with losartan(50~100 mg·d -1 )for 8 weeks.After treatment,Fbg,vWF,P-selectin and PAI-1 were detected again. Results Haemostatic markers (Fbg,vWF,P-selectin,PAI-1)were significantly higher in elderly hypertensive patients compared with controls.Following 8 weeks treatment with enalapril or losartan,there was significant reduction in blood presure and levels of Fbg,vWF,P-selectin,PAI-1. Conclusions Prothrombotic state is present in elderly hypertensive patients and significantly altered by antihypertensive treatment with enalapril or losartan.There is no statistically significant difference between these two drugs.
出处 《实用老年医学》 CAS 2003年第3期129-131,共3页 Practical Geriatrics
关键词 高血压 血栓前状态 依拉普利 氯沙坦 老年人 Hypertension Prothrombotic state Enalapril Losartan The aged
  • 相关文献

参考文献8

  • 1Lip GY, Li-Saw-hee FL. Does hypertension confer a hyperonagulable state? [J]. J Hypertens, 1998,16(7) :913.
  • 2Lee AJ. The role d rehologica] and haemostafic factors in hypertension[J] .J Hum Hypertens, 1997,11(12) :767.
  • 3Lip GY. Flbrinogen and eardiovaseular disorders[J]. QJM, 1995,88(3) : 155.
  • 4Lip GY, Blann AD, Jones AF, et al. Relation of endothelium,thrombogenesis, and haemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy[J] .Am J Carol, 1997,80(12) : 1566.
  • 5Lip GY, Blann AD, Beevers DG.Prothrombotic factors,endothelical function and left venlricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension[J]. J Hypertens, 1999,17(8) : 1203.
  • 6Islim IF, Beevers DG, Bareford D. The effect of antihypertensive drugs on in vivo platelet activity in essential hypertension[J].J Hypertens, 1992,10(4) :379.
  • 7Lerch M, Weidmann P, Ho MP, et al. Metabolic effects d temocapril hypertemive patients with diabetes mellitus type 2[J] .J Cardiovasc Pharmacol, 1999,33(4) :527.
  • 8Goodfeild NE, Newby DE,Ludlam CA, et al. Effects of acute angiotensin Ⅱ Type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolyfic parameters in patients withheart failure[J]. Circulation, 1999,99(23) :2983.

同被引文献146

引证文献12

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部